Clinical Trials Browser

Completed × Thyroid Carcinoma, Anaplastic × pembrolizumab × Clear all

NCT02688608 2022-02-10

Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer

Phase 2 Completed

6 enrolled 10 charts

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT03211117 2020-03-25

Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer

Phase 2 Completed

3 enrolled 7 charts

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic